Brind.
  1. Ascend chips support China's AI self-reliance, with DeepSeek running models on Huawei's chips. Mark Chen leads Huawei Cloud in Latin America as the company studies deployment there.

Huawei and Guangzhou Pharmaceutical Holdings are collaborating to use AI and Ascend chips for drug discovery validation.

4 reports, 1 independent Updated Aug 27
Gone quiet Reached 4 outlets in its first 24 hours
Reports
4
Developments
1
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Huawei and Guangzhou Pharmaceutical Holdings are collaborating to use AI and Ascend chips for drug discovery validation.

Who's involved

What this event is mainly about
HuaweiASCENDGuangzhou Pharmaceutical Holdings

Keep exploring

Part of

Ascend chips support China's AI self-reliance, with DeepSeek running models on Huawei's chips. Mark Chen leads Huawei Cloud in Latin America as the company studies deployment there. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
3 more outlets ran the same wire story